• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·2120.HK
Share

Wenzhou Kangning Hospital Co., Ltd. Stocks

HK$ 11.2Last Updated 20.10.2026

Issuer Rating

4/7
Performance

Strong

Risk

High

Recommendation

Hold

Market Cap

HK$ 99.24M

HK$ 11.2
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Wenzhou Kangning Hospital Co., Ltd. oversees and manages a broad array of healthcare facilities throughout the People's Republic of China. A core part of its mission involves providing specialized psychiatric care. The company's diverse operations also encompass real estate rental and sales, software development and IT solutions, hospital administration, forensic analysis, general medical provisions, and the retail of pharmaceutical products. Established in 1996, the organization was initially known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital before officially adopting its current name, Wenzhou Kangning Hospital Co., Ltd., in October 2014. Its principal offices are situated in Wenzhou, PRC.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalue

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 14:09

Stocks in the memory sector fell by up to 25% last week. Is it worth buying on the dip?

21.10.2026 12:57

Shares of the French retail giant plummeted after the company lowered its forecast amid protests

21.10.2026 12:23

Buying on a Pullback: Why Tom Lee Isn't Worried About the Jitters Surrounding AI Stock Companies

21.10.2026 11:24

The AI market is "almost certainly" in a bubble — billionaire Ken Griffin

21.10.2026 10:45

Netflix issued a weak forecast and scaled back its advertising plans. What is Wall Street saying?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026